CCNA2 was overexpressed in bladder cancer [71], ER+ breast cancer and related to tamoxifen resistance [72], hepatoma with promoting cell proliferation [73] and lung adenocarcinoma [74]. Here, CCNA2 is linked to breast carcinoma.